DEV ENVIRONMENT — dev.library.globalcastmd.com — Changes here do not affect production
0 Views
0 Likes
0 Shares
0 Comments
Read article ↗

StayCurrentMD

View profile →

Article

RNA m6A Methylation Regulates CDH6 to Promote Epithelial-to-Mesenchymal Transition in Cholangiocytes of Biliary Atresia

Published: Reading: 1 min

Topic overview

This research investigates how N6-methyladenosine (m6A) RNA modification regulates the CDH6 gene to drive epithelial-to-mesenchymal transition in cholangiocytes affected by biliary atresia. The study elucidates molecular mechanisms underlying this rare pediatric liver disease, potentially identifying therapeutic targets.

Key takeaways

  • N6-methyladenosine (m6A) RNA modification plays a mechanistic role in biliary atresia pathogenesis.
  • m6A methylation regulates CDH6 expression to drive epithelial-to-mesenchymal transition in BA cholangiocytes.
  • EMT in cholangiocytes represents a key pathologic process in biliary atresia progression.
  • Targeting m6A-CDH6 axis may offer novel therapeutic strategies for biliary atresia management.

Keywords

Biliary Atresia Epithelial-mesenchymal Transition N6-methyladenosine Rna Methylation Cholangiocytes Pediatric Hepatology Cdh6

Hashtags

#BiliaryAtresia #EpithelialMesenchymalTransition #RNAMethylation #PediatricHepatology

Full article text

Full article text not available for this entry
How to cite: GlobalCastMD. RNA m6A Methylation Regulates CDH6 to Promote Epithelial-to-Mesenchymal Transition in Cholangiocytes of Biliary Atresia. GlobalCastMD Medical Library. 2025-08-05. https://dev.library.globalcastmd.com/article/10763?via_space=staycurrentmd

Comments

Loading comments...